Skip to main content

JANUARY 26-27, 2024

OJAI VALLEY INN AND SPA, OJAI, CALIFORNIA

The 17th Annual HCOP Winter Conference boasts a truly impressive lineup that will include a distinguished group of thought leaders such as Peter Goadsby. Dr. Goadsby obtained his medical degree and training at the University of New South Wales (UNSW), Australia. Neurology training was with James W. Lance and clinical neurophysiology with David Burke. After post-doctoral work in New York with Don Reis at Cornell, Jacques Seylaz at Universite VII, Paris, and post-graduate neurology training at Queen Square, London with C David Marsden, Andrew Lees, Anita Harding and W Ian McDonald, he returned to UNSW, and the Prince of Wales Hospital, Sydney as a consultant neurologist and became an Associate Professor of Neurology. He was appointed a Wellcome Senior Research Fellow at the Institute of Neurology, University College London and was Professor of Clinical Neurology and Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London until 2007. He was Professor of Neurology, at University of California, San Francisco.

Currently, Dr. Goadsby is a Professor of Neurology at the University of California, Los Angeles. He is Director, NIHR-Wellcome Trust King’s Clinical Research Facility, King’s College London and Honorary Consultant Neurologist, King’s College Hospital. He is an Honorary Consultant Neurologist at the Hospital for Sick Children, Great Ormond St, London, UK.

Also participating is keynote speaker, Patricia Pozo-Rosich, MD, PhD of Vall d’Hebron University Hospital in Barcelona, Spain. Dr. Pozo-Rosich is the Head of the Headache & Craniofacial Pain Unit at the Vall d’Hebron University Hospital and the Quirón Hospital in Barcelona as well as the Director of the Headache and Neurological Pain Research Group at VHIR (Vall d’Hebron Institute of Research ).

She specialized in the field of headache in the United States and in London in the clinic and laboratories of Professor Stephen Silberstein (Thomas Jefferson University) and Professor Peter Goadsby (University of California at San Francisco and University College London), with the help of the Scholarships of “la Caixa Foundation”, AHS (American Headache Society), EFNS (European Federation Neurological Societies), Rio Hortega, GECSEN (Headache Study Group of the Spanish Neurological Society).

Dr. Pozo-Rosich’s personal leit motiv is to better understand the brain and headache disorders, improve the quality of life of headache sufferers and socially educate professionals, patients and society on how the brain works and interacts with the environment. In order to do this she has promoted and developes a patient/clinician web site (www.midolordecabeza.org) which currently has more than 3,500 registered users and 25,000 facebook followers.

Upon completion of this educational activity, the participant should be better able to:

  1. Gain a better understanding of the role of the brain-gut has in headache disorders including the role of the new GLP1 agonists.
  2. Understand and improve the inequity in healthcare access for headache disorders and how to better reduce disparities in non-majority populations.
  3. Better identify and treat headache syndromes that arise from trauma and PTSD.
  4. Understand the role that C1 plays in migraine and cluster headache both structurally and functionally.
  5. Identify the future of translational migraine research and upcoming treatments.

In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and the Headache Cooperative of the Pacific. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 10.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

BECOME A MEMBER

JOIN US AND BE PART OF A REGIONAL NETWORK OF HEADACHE CAREGIVERS AND RESEARCHERS.

JOIN NOW
CONTACT US 856.599.8465